Pneumatic dilation (PD) and laparoscopic Heller myotomy (LHM) can be defi nitive therapies for achalasia; recent data suggest comparable effi cacy. However, risk must also be considered. We reviewed the major complication rate of PD and LHM in a high-volume center and reviewed the corresponding literature.
INTRODUCTION
Achalasia is a rare neurodegenerative disease selectively involving the esophagus and resulting in absent peristalsis with impaired lower esophageal sphincter relaxation aft er swallowing ( 1 ) . Although there is no cure for the disease, there are highly eff ective treatments to disrupt the lower esophageal sphincter thereby reducing or eliminating esophageal outfl ow obstruction. Endoscopic botulinum toxin injection, pneumatic dilation (PD), laparoscopic Heller myotomy (LHM), open Heller myotomy, and per-oral endoscopic myotomy are all potentially eff ective treatments, but with substantial variability in their respective utilization among centers ( 2, 3 ) . Currently, PD and LHM are the most widely accepted durable therapies for achalasia. However, consensus is lacking as to which treatment is preferable ( 4 ) . Data from a recent European randomized controlled trial comparing these two treatments suggest comparable effi cacy ( 5, 6 ) .
Key to evaluating the relative merits of alternative treatments is an assessment of both benefi t and risk. Ideally, this is done with randomized controlled trials, but in the case of achalasia that is diffi cult owing to the rarity of the disease and the inconsistencies among centers in the fi ne details of the therapies rendered. In the case of LHM, the main variability in technique pertains to the antirefl ux procedure coupled with the myotomy: Dor fundoplasty, Toupet fundoplication, or none at all ( 7, 8 ) . In the case of PD, there has been nearly uniform use of Rigifl ex dilators (Boston Scientifi c, Natick, MA) since the mid 1990s, but enormous variability among centers in dilation protocol and in the utilization of 30, 35, or 40 mm diameter dilators ( 9 ) . A major complication of both PD and LHM is esophageal perforation and these
Major Complications of Pneumatic Dilation and Heller
Myotomy for Achalasia: Single-Center Experience and Systematic Review of the Literature technical variables likely impact on the magnitude of that risk. Given the recent data suggesting equivalence between PD and LHM in terms of effi cacy ( 5 ), we thought it timely to compare complication rates of the two procedures in the hands of relatively few highly experienced operators at a single, high-volume institution. Hence, we reviewed our 12-year experience of complications from PD and LHM and compared it with the published data obtained from a systematic review of the literature pertinent to the same procedures.
METHODS

Northwestern experience
We searched the clinical database of Northwestern Memorial Hospital for the period encompassing the lifespan of its electronic medical record (January 2000 to our cutoff of November 2011) for achalasia, esophageal dilation, and myotomy; ICD-9 CM codes for achalasia (530.0), esophagomyotomy (42.7), esophageal dilation (42.92), and perforation of esophagus (530.4) were used. Medical records were individually reviewed to confi rm that patients underwent PD or LHM as verifi ed by review of the procedure notes. LHM review also included procedures 2 years before this period as that aspect of the medical record extended back to 1998. Dilations other than those done with Rigifl ex dilators, open myotomies, and per-oral endoscopic myotomies were excluded. Dilations done with smaller balloon dilators or bougie dilators were not included; there were no other achalasia-type dilators used at our center during this interval. Procedure notes, post-operative notes, inpatient notes, and post-operative imaging for up to 30 days post procedure were reviewed for evidence of post-operative perforation or death. Perforations that occurred intraoperatively during LHM were excluded as these were judged to be clinically insignifi cant. Treatment outcome was assessed by chart review of post-procedure clinic visits at 3 months and by a telephone survey administered for the purposes of this study to patients (or, in some cases, their spouses or children) 3 months to 10 years post procedure assessing dysphagia over the past 30 days ( Figure 1 ).
Literature review
Studies reporting complication experiences for LHM and PD were identifi ed from the literature using the Ovid and PubMed search engines for our medical school library. Th is was done using the search words " esophageal achalasia, " " balloon dilation, " and " Heller myotomy " for English language publications. Reference lists from papers identifi ed with the search were also scrutinized for potentially relevant secondary citations. Studies were included if they met the following criteria: they were consecutive series, they encompassed at least 50 procedures, the method and type of dilator and / or operative technique used were specifi ed, complication data for at least 1 month post procedure were reported, and the occurrence of post-operative esophageal perforation was specifi cally addressed. Studies on PD were only included if Rigifl ex dilators were used. Identifi ed publications were reviewed independently by two of the authors. Any disagreements between them were to be resolved by consensus.
Statistical analysis
Comparison of post-procedure perforations and deaths in patients who underwent PD vs. LHM was made using Fisher ' s exact test.
RESULTS
Northwestern experience
During our 12-year experience, 463 achalasia patients underwent a total of 567 PD and LHM procedures ( highly experienced gastroenterologists with prior experience of at least 75 procedures each performed all of the PDs using a very similar protocol. Th e essential details of that protocol were (i) use of fl uoroscopy for guidewire control and localization of the dilation balloon, (ii) initial dilation procedure using only a 30-mm Rigifl ex dilator, (iii) balloon infl ation was done only once providing that that there was good visualization of the sphincter on the fl uoroscopic silhouette of the dilator and that full eff acement of the dilator silhouette was achieved (in instances that this was uncertain, the balloon was defl ated, repositioned, and infl ation repeated until the sphincter was confi dently localized), (iv) there was no pre-specifi ed target infl ation pressure and no notation was made of infl ation pressure, (v) the balloon dilator was defl ated aft er sphincter eff acement was evident by fl uoroscopy with no pre-specifi ed duration of infl ation, (vi) Gastrografi n swallows were routinely obtained by one operator, and not routinely obtained by the other operators, and (vii) the identical protocol was repeated with a 35-mm Rigifl ex dilator (or in some cases 30 mm) 2 -52 weeks aft er the 30-mm dilation in instances of inadequate symptomatic response and rapid recurrence of lower esophageal sphincter dysfunction as verifi ed by follow-up manometric and / or timed barium swallow evaluation. Th e 40-mm Rigifl ex dilator was not used at all in this series. During the same 12-year period, six operators performed LHM with a Dor fundoplasty (68 % ) or Toupet fundoplication. All operators used a similar technique performing an anterior myotomy with extension 6 -8 cm up the esophagus and 2 -3 cm onto the stomach to capture the gastric sling fi bers.
Th ere were seven clinically signifi cant perforations in our series; six post-LHM and one post-PD ( Table 2 ). Among these, only one patient had a prior achalasia treatment (botulinum toxin injection). Th ree of these perforations, including the one following PD, were managed operatively. Th ere were no deaths resultant from these perforations.
Two patients died post-Heller myotomy of complications other than esophageal perforation. One patient developed rapid atrial fl utter post-operatively requiring treatment with intravenous anti-arrhythmic drugs. A barium swallow image 1 day post-operatively showed no evidence of a leak. However, repeat imaging 2 days later showed a possible contained leak. Shortly aft er this image was obtained, the patient developed polymorphic ventricular tachycardia and could not be resuscitated. Th e patient was afebrile with a normal white blood cell count at that time. No autopsy was obtained. Th e second death involved a splenic capsular tear sustained during LHM leading to hemodynamic instability. Th e patient required aggressive fl uid resuscitation and blood transfusions, complicated by acute respiratory failure and death. Perforation or death combined was signifi cantly more frequent post-LHM than post-PD ( P = 0.02).
Patients who did not achieve an adequate clinical response to their initial PD underwent further treatment. Th e primary criterion for repeat dilation was an inadequate symptomatic response with respect to dysphagia. Before a second dilation being done, a repeat manometry and / or timed barium swallow were done to corroborate persistent sphincter dysfunction. Th e criterion for sphincter dysfunction on high-resolution manometry was an integrated relaxation pressure of > 15 mm Hg. On studies done before the introduction of the high-resolution manometry, the criterion was of a nadir relaxation pressure of > 10 mm Hg. Th e criterion on a timed barium swallow was of a barium column height of > 5 cm. Of the 184 patients who underwent initial treatment with PD, 118 (64 % ) had a single PD and did not require repeat PD or LHM. Twenty-seven percent had subsequent PD (almost all 35 mm) and there were 16 (8.7 % ) patients who ultimately underwent myotomy aft er PD. Th ese results are summarized in Figure 2 . Th us, based on the need for further therapy, 91 % of patients were adequately treated by PD.
Attempts were made to contact 123 PD patients by phone of whom 48 proved unreachable and 9 were deceased, leaving 66 (54 % ) who were successfully interviewed. Among these individuals, sixty (91 % ) had a satisfactory response to PD, reporting less than one occurrence a month of odynophagia, trouble swallowing liquids, trouble eating soft foods, or choking. Of the remaining six, fi ve had a moderate response reporting some scores of three or four on the phone survey ( Figure 1 ) and one patient reported a poor response evident by some scores greater than four. Nonetheless, these six patients pursued no further treatment.
Literature review
Th e specifi ed inclusion criteria for the literature search identifi ed 80 studies suitable for review ( Figure 3 ). Th ese studies reported on a total of 6,834 patients treated with LHM ( Table 3a ) and 5,660 with PD ( Tables 3b and 3c ). Th e methodology utilized for LHM among studies was generally consistent with that used at our center as was the experience with complications. However, the methodology used for PD among centers was highly variable and oft en more aggressive ( Tables 3b and 3c ) . Furthermore, the pooled perforation rate was greater than in our series.
DISCUSSION
PD and LHM are the mainstay treatments for achalasia and the recent data suggest them to have similar effi cacies ( 5 ). However, in weighing the relative merits of the techniques, risk as well as benefi t must be considered in selecting between these options. Th e major fi nding from our retrospective analysis was that the risk of perforation from PD was modest when done with a consistent conservative protocol in a high-volume setting by a select group of highly experienced operators. In fact, the risk of 
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Mattioli ( 52 ) perforation or 30-day mortality following PD was signifi cantly lower than the combined risk of perforation or post-operative mortality from LHM in the same practice setting. Esophageal perforation is the most common major complication for both LHM and PD with varying rates reported in the literature. Th e rate of clinically signifi cant esophageal perforation reported in the literature for PD and LHM ranged from 0 to 14 % and from 0 to 4.6 % , respectively ( 10 -12 ). As seen in Tables 3a -3c , perforation and mortality rates varied greatly by institution. Th is variation can probably be explained by diff erences in technique, number, and experience of operators, and the size of the reported experience. Th e esophageal perforation rate from PD at our center (0.37 % ) was notably lower than most previously reported series, and was also lower than that associated with LHM. Th us, the risk of esophageal perforation from PD appears to be at least partly dependent on PD technique and operator experience, two variables that were held relatively constant at our center for the duration of the 12-year period reviewed.
One potential explanation for the wide range of perforation reported for PD is publication bias with relatively few large studies reporting low rates and some small series tending to report high perforation rates. Figure 4 illustrates the relationship between case series size and perforation rate from our literature search of series of PD performed with a Rigifl ex balloon; the perforation rate from our institution is displayed as a square symbol in Figure 4 . Studies with a small number of procedures have generally reported higher perforation rates (or none at all). A notable exception is the study by Sanchez-Pernaute (75) in which there were 15 perforations from 330 PDs using only a 35-mm Rigifl ex balloon. With the exception of this outlier, there are no studies with large numbers of procedures and a high percentage of perforations. An additional consideration is that we report our perforation data both per procedure and per patient rather than only per patient as some have done in the past.
Patients who did not achieve full response to their initial treatment underwent repeated procedures. Of the 184 patients who underwent initial treatment with a PD, 118 (64 % ) underwent no further treatment. Th ese can be considered as treatment successes, as inferred by the lack of need for further procedures. Sixteen (8.7 % ) patients ultimately underwent LHM aft er PD and were considered as treatment failures. Th is is comparable to effi cacy rates reported in prior studies ( 5 ) . Alternatively, effi cacy was also assessed by a phone survey administered to patients who were not referred on for LHM; among the 66 patients successfully contacted and interviewed, 91 % reported a good response to PD. Th at result needs to be qualifi ed, however, in view of the fact that only 54 % of the intended population was available for follow-up and the instrument used for assessment had not been specifi cally validated for achalasia.
Death is a very rare consequence of achalasia treatment. Th ere were no deaths in our entire PD experience. With respect to LHM, the pooled all-cause mortality rate was 0.15 % ( Table 3a ) . Similarly, the 30-day mortality for LHM at our center was low (0.68 % ). Th ese deaths were attributable to a variety of post-operative issues such as urinary tract infection, pulmonary embolus, and myocardial infarction with very few being directly related to the myotomy itself.
In conclusion, we have reviewed our large single-center experience to compare the complication rates of PD and LHM in the treatment of achalasia. In our 463 patient experience, both modalities had low complication rates and mortality, with that of PD Post-procedural perforations (%) Number of patients (n) 4 5 6 being signifi cantly lower than that of LHM. Review of the literature suggests that a low perforation rate is consistent with that of other high-volume achalasia treatment centers. Th us, in selecting between these treatment options, the risk side of the equation may slightly favor PD. Of course, there are other considerations in making this choice such as relative effi cacy in treating dysphagia, the likelihood of post-procedure refl ux, the manometric subtype of achalasia, and the severity of anatomical distortion associated with advanced disease. However, these considerations can only be optimally addressed by randomized controlled trials that currently do not exist. Consequently, with the currently available data suggesting equivalence between PD and LHM, PD should remain a mainstay treatment option in the primary treatment of idiopathic achalasia.
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Study Highlights
WHAT IS CURRENT KNOWLEDGE
3 A major complication of both defi nitive therapies for achalasia (pneumatic dilation (PD) and laparoscopic Heller myotomy (LHM)) is esophageal perforation and technical variables likely impact on the magnitude of that risk.
3 Recent data suggest equivalence between PD and LHM in terms of effi cacy.
WHAT IS NEW HERE
3 The actual perforation rate from pneumatic dilation (PD) in a large single-center experience using a uniform conservative methodology was 1 / 272 (0.37 % ), lower than reported in prior studies that may have been infl uenced by publication bias.
3 In comparing PD and laparoscopic Heller myotomy, the risk side of the equation favored PD in this series.
